FMD Ignights Both Physiological and Behavioral Reset

In the evolution of medicine, there are very few milestones whereby an innovation changes the course of a major disease - and a new study, and our new revolutionary patent and program, puts the possibility of type 2 diabetes remission within reach!   

L-Nutra is at the forefront of the Nutrition as Medicine movement, offering a beacon of light in the future of healthcare, emphasizing care for the entire body and offering a more comprehensive, sustainable path to wellness. In our quest for revolutionizing healthcare, it's crucial to acknowledge the valuable role medications play in treating various conditions; yet, while medications are undoubtedly instrumental in managing various conditions, it's equally important to recognize their limitations in taking a whole-body comprehensive approach.   

In America, diabetes is an epidemic, with over 30 million people suffering from diabetes, and nearly 98 million who are prediabetic. Despite medications being able to control blood sugar, they often slow the condition, and even with advances in new medications over the last decade, glycemic control - the concentration of glucose in the blood - declined in adults with diabetes in the U.S. There is a need for a paradigm shift in diabetes care, the use of nutrition as medicine – and we are leading the charge!  

Diabetes is traditionally thought to be a chronic, progressive, incurable condition, when, in fact, type 2 diabetes is highly correlated to nutrition, lifestyle, and biological aging, and can benefit from changes in diet and nutrition, and if possible, the reversal of the body’s bioage. So, what if there was a breakthrough scientific Nutrition Technology that could manage type 2 diabetes, decrease the need for medication, and in some cases eliminate all needs for medication? There is! The Fasting Mimicking Nutrition Program, which was just launched by L-Nutra Health.  

The effects of FMD on type 2 diabetes management are profound and the research groundbreaking. In those with type 2 diabetes using FMD, a 6-month study from 2022 showed:   

• 53% improvement in Glycemic Management    
• 67% reduction in medication   
• 22 lbs. weight loss and reduced BMI and waist circumference, without the loss of muscle mass   
• 1.4% A1C reduction   
• 59% reduced insulin resistance   

And a pioneering new study also focused on the effects of FMD on type 2 diabetes management was recently published. Both studies have shown major cardiometabolic reset due to FMD, and this new study further demonstrates its benefits, with astounding results: 
 

• Medication Reduction: Participants in the FMD group were eight times more likely to reduce their medication dosage. Furthermore, 56% either stopped or reduced their medications, a stark contrast to the 10% in the control group. 
• Glycemic Management: FMD participants demonstrated superior glycemic management, with 53% showing improvement, compared to only 8% in the control group. 
• Insulin Sensitivity: The study highlighted enhanced insulin sensitivity among FMD participants, suggesting an improved response to insulin. 
• Anthropometric Benefits: Positive reductions were observed in weight, BMI, waist circumference, and body fat percentage without loss in fat-free mass.
   

How does it work? The Fasting Mimicking Diet (FMD) impacts the root cause of type 2 diabetes through targeting factors such as cellular rejuvenation, muscle protection, weight loss (mainly from central fat), insulin sensitivity, and potentially reduced biological age score. This clinically tested FMD program is easy to use (83% compliance) and supports major cardiometabolic changes within just 6 months, including two-thirds of patients reducing either their dosage or need for medications.  

And now, L-Nutra Health (LNH), the medical division of L-Nutra, has taken this science to develop and offer the first of its kind, first ever patented Diabetes Remission and Regression Program.  Our trailblazing 12-month program has an emphasis on reduction in medications and improved health outcomes. With a comprehensive regimen that includes a unique FMD formulated for better glucose management, telehealth professionals to help manage medication use during the program, Dietitian consults, digital tools, and laboratory monitoring designed to support disease regression safely and effectively, LNH is ushering in a new era of diabetes care.   

The implications of our L-Nutra Health program are potentially life-changing. We are studying its use, upcoming, for a range of chronic diseases, including cardiovascular disease, cancer, Alzheimer's, and autoimmune diseases. As L-Nutra continues to be a world leader in expanding the sector of enhanced longevity, we invite you to join us on this journey and encourage you to learn more about our revolutionary 12-month Diabetes for Regression and Remission program here; together, we can unlock the full potential of nutrition-led approaches of FMD and pave the way for a healthier, happier, and more vibrant world!